No permission for SII to conduct trial on kids

An expert panel of the country's central drug authority on Wednesday recommended against granting permission to the Serum Institute of India (SII) to conduct the phase 2/3 trial of Covid-19 vaccine Covovax on children aged two to 17 years, sources said.

from Times of India https://ift.tt/3yefZ1M
via IFTTT

Comments

Popular posts from this blog

Furore in IIT-Bombay over talks on Hamas, Hinduism

HC: Treat arrest, even without exchange of fire, as encounter